Undergraduate, University of Lausanne, Switzerland
PhD, University Hospital of Lausanne (CHUV), Switzerland
The principal objective of my work is improve our understanding of two distinct components of the dynamic between tumors and T cells: what are tumor rejection antigens and what are the T-cell features associated with better efficacy, both key questions in the development of novel personalized therapies.
Ludwig Institute for Cancer Research, Lausanne
Agora Research Center
Rue du Bugnon 25A, CH-1005 Lausanne
T (41) 21 545 10 77
F (41) 21 692 59 95